Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
11 July 2021 - 1280
Bactericidal activity of ethionamide alone and boosted by BVL-GSK098 in an acute murine model of tuberculosis
Thomas Maitre, T. Maitre (1), S. Lociuro (2), M. Pieren (2), A. Chauffour (1), L. Fournier Le Ray (1), A. Aubry (1, 3), N. Willand (4), A. Baulard (5), M. Remuiñán (6), J. Rullás (6), G. Dale (2), M. Gitzinger (2), N. Veziris (1, 3, 7)
11 July 2021 - 854
How to turn an old drug into a potent, rapidly bactericidal and safer drug: clinical candidate BVL-GSK098 overcomes resistance to and potentiates the activity of ethionamide by boosting ethionamide bioactivation in Mycobacterium tuberculosis
Alain Baulard, A. Baulard (1), N. Willand (2), R. Frita (3), M. Flipo (2), B. Deprez (2), M. Remuiñán (4), A. Mendoza (4), M.J. Rebollo (4), E. Pérez-Herrán (4), D. Barros (4), A. Trauner (5), S. Gagneux (6), V. Trebosc (5), C. Kemmer (5), M. Bourotte (3), M. Gitzinger (5), G. Dale (5), M. Pieren (5), S. Lociuro (5)
10 July 2021 - 2550
Inhibition of AgrA-mediated virulence factor expression in MRSA: a viable, non-lethal, treatment option
Andrej Trauner, A. Trauner (1), J. Schill (1), A. Michelotti (2), A. Ballee (2), S. Söderholm (3), C. Kemmer (1), B. Schellhorn (1), V. Lucchini (1), M. Pieren (1), V. Trebosc (1), O. Defert (2), M. Bourotte (2), M. Gitzinger (1), D. Bumann (3), G. Dale (1), S. Lociuro (1)
09 July 2021 - 863
Therapeutic efficacy of ethionamide boosted with BVL-GSK098 in an acute murine model of tuberculosis
Modesto Remuiñán, M. Remuiñán (1), J. Rullás (1), L. Guijarro (1), D. Barros (1), N. Willand (2), M. Flipo (2), B. Deprez (2), A. Baulard (3), R. Frita (4), M. Gitzinger (5), G. Dale (5), M. Pieren (5), S. Lociuro (5)
23 April 2018 - P1661
Murepavadin activity tested against contemporary (2016-2017) clinical isolates of extensively drug-resistant (XDR) Pseudomonas aeruginosa
David Greig, H. Sader, R. Flamm, G. Dale, P. Rhomberg, M. Castanheira
23 April 2018 - P1668
Outer membrane protein targeting antibiotics (OMPTAs): investigation of the in vitro time-kill kinetics and rate of resistance development by serial passage
Sachin Bhagwat, F. Bernardini, C. Verbree, S. Stiegeler, P. Chiquet, G. Dale
23 April 2018 - P1667
Investigation of the in vitro time-kill kinetics and the rate of resistance development by spontaneous mutations and serial passage of murepavadin and standard-of-care antibiotics towards P. aeruginosa
Karin Meinike Jørgensen, F. Bernardini, P. Chiquet, C. Verbree, S. Stiegeler, G. Dale
23 April 2018 - P1662
Antimicrobial activity of murepavadin tested against clinical isolates of Pseudomonas aeruginosa collected in Europe, the United States and China
Marjan Wouthuyzen-Bakker, H. Sader, G. Dale, L. Duncan, P. Rhomberg, R. Flamm
23 April 2018 - P1665
Outer membrane protein targeting antibiotics (OMPTAs): in vivo characterization of a novel class of compounds with respect to pharmacokinetics, efficacy and renal toxicity
Glenn Dale, G. Dale, A. Luther, J. Teague, D. Markovic, F. Bernardini, D. Obrecht
23 April 2018 - P1666
Outer mebrane protein targeting antibiotics (OMPTAs): a novel class with potent in vitro and in vivo activity against E. coli-harbouring mcr-1 and/or mcr-3 genes
Glenn Dale, G. Dale, J. Teague, C. Vingsbo Lundberg, A. Luther, F. Bernardini, D. Obrecht
21 April 2018 - O0246
Outer membrane protein targeting antibiotics (OMPTAs): a novel class with potent activity against Gram-negative organisms including XDR and colistin-resistant isolates
Anatol Luther, A. Luther, F. Bernardini, G. Dale, C. Verbree, S. Stiegeler, P. Chiquet, D. Obrecht
11 April 2016 - P1307
Metabolism and excretion of the novel macrocycle antibiotic POL7080
Catherine Hogan, Dale Glenn, O. Kuhlmann, C. Brealey, S. Simon, M. Ullah, M. Pantze, A. Wach, G. Dale
11 April 2016 - P1308
Pharmacokinetics and safety of POL7080 in subjects with impaired renal function
Catherine Hogan, Dale Glenn, A. Halabi, M. Peterson-Sylla, K. Sommerville, A. Wach, K. Dembowsky, M. Rangaraju, G. Dale
11 April 2016 - P1309
Pharmacokinetics of POL7080 co-administered with standard of care (SoC) in patients with ventilator-associated pneumonia (VAP) due to suspected or documented Pseudomonas aeruginosa infection
Catherine Hogan, Dale Glenn, A. Armaganidis, F. Frantzeskaki, C. Diakaki, S. Zakynthinos, E. Ischaki, K. Mandragos, C. Katsenos, M. Paraschos, M. Patrani, E. Giamarellos-Bourboulis, N. Antonakos, G. Damoraki, M. de la Torre-Prados, K. Sommerville, M. Rangaraju, K. Dembowsky, L. Hooftman, A. Wach, G. Dale, A. Torres
10 April 2016 - O288
Interim analysis of the efficacy of POL7080 co-administered with standard-of-care (SoC) in a phase II study in patients with ventilator-associated pneumonia (VAP) due to suspected or documented Pseudomonas aeruginosa infection
Apostolos Armaganidis, Armaganidis Apostolos, A. Armaganidis, F. Frantzeskaki, C. Diakaki, . Apostolopoulou, S. Zakynthinos, E. Ischaki, K. Mandragos, C. Katsenos, M. Paraschos, M. Patrani, E. Giamarellos-Bourboulis, A. Pistiki, T. Tsaganos, P. Ramirez Galleymore, M. de la Torre-Prados, M. Rangaraju, K. Dembowsky, L. Hooftman, G. Dale, A. Torres
09 April 2016 - P0345
Activity of novel antibiotic POL7080 against clinical isolates from a surveillance programme in CN (2012 and 2013)
Catherine Hogan, Dale Glenn, Buhl Michael, G. Dale, P. Rhomberg, I. Najera, C. Zampaloni, R. Flamm
Loading ...
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.